COMMUNIQUÉS West-GlobeNewswire

GW Pharmaceuticals to Report Fourth Quarter and Year-End Financial Results and Host Conference Call on 27 November, 2018
06/11/2018
LONDON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Antares Pharma Reports Third Quarter 2018 Operating and Financial Results
06/11/2018
The Company Posts Record Quarterly Revenue Of $17.9 Million EWING, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the Company) today announced operating and financial results for the third [...]
BioCryst Reports Third Quarter 2018 Financial Results
06/11/2018
APeX-2 study enrollment completed, results on-track for Q2 2019 RESEARCH TRIANGLE PARK, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the [...]
Imprimis Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 13, 2018
06/11/2018
SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced it will release third quarter 2018 financial results after the close of trading on Tuesday, November 13, 2018. [...]
Ritter Pharmaceuticals Announces Closing of $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
06/11/2018
Proceeds Expected to be Sufficient to Fund Company’s Liberatus Phase 3 Clinical Trial for RP-G28 for Lactose Intolerance Through Announcement of Top-Line Data Anticipated in the Second Half of 2019 LOS ANGELES, Nov. 06 [...]
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
06/11/2018
GAITHERSBURG, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences [...]
Neuronetics Reports Third Quarter 2018 Financial and Operating Results
06/11/2018
MALVERN, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
Managers’ transactions
06/11/2018
Company Announcement No. 20/2018 November 6, 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 [...]
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights
06/11/2018
Debuted its next 12-18 months’ immuno-oncology clinical development programs for both hematologic malignancies and solid tumors to key opinion leaders, investment and industry executives Licensed patents from the [...]
Madrigal Pharmaceuticals Reports 2018 Third Quarter Financial Results and Highlights Upcoming Clinical Events
06/11/2018
CONSHOHOCKEN, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) today announced its third quarter 2018 financial results and described upcoming clinical events: “Madrigal made important [...]
Loxo Oncology to Participate in Upcoming Investor Conferences
06/11/2018
STAMFORD, Conn., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
Tetra Bio-Pharma Enters into Non-Binding Proposal to Acquire Panag Pharma Inc.
06/11/2018
The Proposed Transaction is expected to provide Tetra: With the most robust Pharmaceutical and Natural Health Products (NHP) pipeline of any Cannabinoid company; With more pharmaceutical and natural health products; The [...]
ChromaDex Appoints Matthew Roberts as Chief Scientific Officer and Senior Vice President of Innovation
06/11/2018
LOS ANGELES, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Matthew Roberts as Chief Scientific Officer and Senior Vice President of Innovation, effective [...]
Syneos Health Reports Third Quarter 2018 Results
06/11/2018
Highlights GAAP total revenue of $1.11 billion and $3.24 billion for the three and nine months ended September 30, 2018, respectively. Combined Company ASC 606 adjusted service revenue of $1.12 billion and $3.26 billion [...]
Tabula Rasa HealthCare Announces Third Quarter 2018 Operating Results
06/11/2018
Third Quarter 2018 Revenue of $54.4 million, growth of 66%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare [...]
HealthLynked Corp. Announces the Addition of Dr. Maher Albitar to its Scientific Advisory Board
06/11/2018
NAPLES, Fla., Nov. 06, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced that Maher Albitar M.D. will be joining the company’s Scientific Advisory Board (SAB). HealthLynked is an innovative [...]
EyePoint Pharmaceuticals Reports Fiscal First Quarter 2019 Financial Results and Highlights Recent Clinical and Operational Developments
06/11/2018
-YUTIQ ™ approved by U.S. FDA; anticipated launch in calendar 1Q19- -Exclusive license granted to Ocumension Therapeutics to develop and commercialize EyePoint’s three-year micro-insert product using the Durasert™ [...]
Invitation: Terveystalo Plc Q3 result - webcast and conference call on 14 November 2018
06/11/2018
Terveystalo Plc will publish its Interim report for January-September 2018 on 14 November at 9:00 EEST. (Finnish time). The English live webcast and conference call will be held on 14 November at 11:30 Finnish time ( [...]
Helsinn Group supports Satellite Symposium at 14th EADO Congress 2018
06/11/2018
Helsinn Group supports Satellite Symposium at 14 th EADO Congress 2018 Lugano, Switzerland, November 6, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that [...]

Pages